Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline

Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline - European Society for Medical Oncology (ESMO)

This guideline provides recommendations for risk-reduction and screening for individuals with a hereditary breast and ovarian cancer syndrome.

This guideline focuses on risk-reduction and screening mainly in unaffected carriers and particularly in high-resource settings.

The panel encompasses an international multidisciplinary group of experts.

Recommendations are based on available scientific data and the authors’ collective expert opinion.


Read full Guideline